NCT05516862 is a NA clinical trial of Dragons acupuncture in PTSD, sponsored by Paul Crawford.

Who is sponsoring NCT05516862?

NCT05516862 is sponsored by Paul Crawford.

What drugs are being tested in NCT05516862?

Interventions in NCT05516862: Dragons acupuncture, Dragons acupressure, Dragons placebo.

What condition does NCT05516862 study?

NCT05516862 studies PTSD, Post Traumatic Stress Disorder, Acupuncture.

Is NCT05516862 still recruiting?

NCT05516862 is currently recruiting now. Last updated 19 September 2025.

Last reviewed 2025-09-19 · How we verify

NCT05516862

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Determining the Right Acupuncture for Good Recovery Over Neuropsychiatric Trauma

Recruiting now NA Last updated 19 September 2025

What this trial tests

NA trial testing Dragons acupuncture in PTSD in 75 participants. Currently enrolling.

Timeline

1 October 2022

Primary endpoint
1 October 2026

1 October 2026

Quick facts

Lead sponsor	Paul Crawford
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	75
Start date	1 October 2022
Primary completion	1 October 2026
Estimated completion	1 October 2026
Sites	1 location across United States

Drugs / interventions tested

Dragons acupuncture
Dragons acupressure
Dragons placebo

Conditions studied

PTSD — all drugs for PTSD →
Post Traumatic Stress Disorder — all drugs for Post Traumatic Stress Disorder →
Acupuncture — all drugs for Acupuncture →

Sponsor

Paul Crawford

Who can join

Adults 18 to 74, any sex, with PTSD or Post Traumatic Stress Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study seeks to verify that a specific acupuncture treatment is effective at reducing symptoms of neuropsychiatric trauma found in those diagnosed with Post-Traumatic Stress Disorder (PTSD).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for PTSD

Currently open trials in the same condition.

NCT07473505 — Integrative Bilateral Cervical Sympathetic Blocks for Trauma-Related Symptoms in Special Operations Veterans: A Prospect · recruiting
NCT07010757 — Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial · NA · recruiting
NCT07372586 — Behavioral Health Collaborative Care Model in an ICU Recovery Clinic · NA · recruiting
NCT07390786 — Behavioral Health Collaborative Care Model in Post-ICU Clinic Family Pilot · NA · recruiting
NCT07469098 — Group vs Individual MDMA-Assisted Therapy for PTSD After the October 7, 2023 Events · Phase 2 · recruiting

Other Paul Crawford trials

Trials by the same sponsor.

NCT04464954 — BFA Treatment of Pain · NA · completed
NCT03945240 — Evaluating Different Low-level Laser Therapies to Treat Neck Pain in Air Force Pilots and Flight Crew · NA · terminated
NCT04011176 — Microcurrent Treatment for Chronic Debilitating Pain · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05516862 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Paul Crawford
Last refreshed: 19 September 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05516862.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing